The rising interest in GLP-1 agonists for metabolic conditions has led to a debate about delivery routes : transdermal systems versus tablets . Traditionally , GLP-1 drugs were solely available in tablet https://denismapt492828.blogminds.com/glp-1-transdermal-delivery-systems-vs-pills-is-right-for-the-patient-37819681